Show simple item record

dc.contributor.authorKennedy, Nicholas A
dc.contributor.authorLamb, Christopher A
dc.contributor.authorBerry, Susan H
dc.contributor.authorWalker, Alan W
dc.contributor.authorMansfield, John
dc.contributor.authorParkes, Miles
dc.contributor.authorSimpkins, Rachel
dc.contributor.authorTremelling, Mark
dc.contributor.authorNutland, Sarah
dc.contributor.authorUK IBD Genetics Consortium
dc.contributor.authorParkhill, Julian
dc.contributor.authorProbert, Chris
dc.contributor.authorHold, Georgina L
dc.contributor.authorLees, Charlie W.
dc.date.accessioned2018-02-20T10:31:08Z
dc.date.available2018-02-20T10:31:08Z
dc.date.issued2018-03
dc.identifier.citationKennedy , N A , Lamb , C A , Berry , S H , Walker , A W , Mansfield , J , Parkes , M , Simpkins , R , Tremelling , M , Nutland , S , UK IBD Genetics Consortium , Parkhill , J , Probert , C , Hold , G L & Lees , C W 2018 , ' The Impact of NOD2 Variants on Fecal Microbiota in Crohn’s Disease and Controls Without Gastrointestinal Disease ' , Inflammatory Bowel Diseases , vol. 24 , no. 3 , pp. 583-592 . https://doi.org/10.1093/ibd/izx061en
dc.identifier.issn1078-0998
dc.identifier.otherPURE: 115284093
dc.identifier.otherPURE UUID: 10757943-033f-48f1-99df-a2c518f2322f
dc.identifier.otherScopus: 85050148688
dc.identifier.otherORCID: /0000-0001-5099-8495/work/42316360
dc.identifier.urihttp://hdl.handle.net/2164/10060
dc.descriptionFunding was supported by CORE, the Digestive Diseases Foundation and the Wellcome Trust [grant number 097943 to NAK, 093885 to CAL and 098051 to Alan W Walker and Julian Parkhill . Dr. Walker receives core funding support from the Scottish Government Rural and Environmental Science and Analysis Service (RESAS). We also acknowledge the NIHR Biomedical Research Centre awards to Addenbrooke’s Hospital/University of Cambridge School of Clinical Medicine and acknowledge the NIHR Newcastle Biomedical Research Centre.en
dc.format.extent10
dc.language.isoeng
dc.relation.ispartofInflammatory Bowel Diseasesen
dc.rights© The Author(s) 2018. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.subjectCrohn’s diseaseen
dc.subjectNOD2en
dc.subjectmicrobiotaen
dc.subjectgenotypeen
dc.subjectR Medicineen
dc.subjectWellcome Trusten
dc.subject.lccRen
dc.titleThe Impact of NOD2 Variants on Fecal Microbiota in Crohn’s Disease and Controls Without Gastrointestinal Diseaseen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Rowett Instituteen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1093/ibd/izx061
dc.identifier.vol24en
dc.identifier.iss3en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record